Relationship between platelet count and bleeding risk in thrombocytopenic patients

Transfusion Medicine Reviews

Volumn 18, Issue 3, 2004, Pages 153-167

  Slichter, Sherrill J ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b PUGET SOUND BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; DISEASE PREDISPOSITION; DISSEMINATED INTRAVASCULAR CLOTTING; HEMOSTASIS; HUMAN; MORTALITY; PREDICTION; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SENESCENCE; SOLID TUMOR; STEM CELL TRANSPLANTATION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 3242662722     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2004.03.003     Document Type: Article

References (47)

1. Kitchens C.S., Weiss L. Ultrastructural changes of endothelium associated with thrombocytopenia. Blood. 46:1975;567-578
2. Tranzer J.P., Baumgartner H.R. Filling gaps in the vascular endothelium with blood platelets. Nature. 216:1967;1126-1128
3. Aursnes I. Blood platelet production and red cell leakage to lymph during thrombocytopenia. Scand J Haematol. 13:1974;184-195
4. Hanson S.R., Slichter S.J. Platelet kinetics in patients with bone marrow hypoplasia Evidence for a fixed platelet requirement. Blood. 56:1985;1105-1109
5. Harker L.A. The role of the spleen in thrombokinetics. J Lab Clin Med. 77:1971;247-253
6. Harker L.A., Slichter S.J. Platelet and fibrinogen consumption in man. N Engl J Med. 287:1972;999-1005
7. Gaydos L.A., Freireich E.J., Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. New Eng J Med. 266:1962;905-909
8. Slichter S.J., Harker L.A. Thrombocytopenia Mechanisms and management of defects in platelet production. Clin Haematol. 7:1978;523-539
9. Han T., Stutzman L., Cohen E., et al. Effect of platelet transfusion on hemorrhage in patients with acute leukemia. An Autopsy Study. Cancer. 19:1966;1937-1942
10. Roy A.J., Jaffe N., Djerassi I. Prophylactic platelet transfusions in children with acute leukemia A dose response study. Transfusion. 13:1973;283-290
11. Hamajima N., Sasaki R., Aoki K., et al. A notable change in mortality of aplastic anemia observed during the 1970s in Japan. Blood. 72:1988;995-999
12. Higby D.J., Cohen E., Holland J.F., et al. The prophylactic treatment of thrombocytopenic leukemia patients with platelets A double blind study. Transfusion. 14:1974;440-446
13. Murphy S., Litwin S., Herring L.M., et al. Indications for platelet transfusion in children with acute leukemia. Am J Hematol. 12:1982;347-356
14. Solomon J., Bofenkamp T., Fahey J.L., et al. Platelet prophylaxis in acute non-lymphoblastic leukemia. Lancet. 1:1978;267. (letter)
15. Ilett S.J., Lilleyman J.S. Platelet transfusion requirements of children with newly diagnosed lymphoblastic leukemia. Acta Haematol. 62:1979;86-89
16. Sintnicolaas K., Vriesendorp H.M., Sizoo W., et al. Delayed alloimmunization by random single donor platelet transfusions. A randomized study to compare single donor and multiple donor platelet transfusions in cancer patients with severe thrombocytopenia. Lancet. 1:1981;750-754
17. Wandt H., Reinel H., Schaefer-Eckart K., et al. New strategy for platelet transfusion in patients with acute myeloid leukemia Routine prophylactic transfusion replaced by therapeutic transfusion. Blood. 100:2002;706a. (abstr)
18. Schaefer-Eckart K., Reinel H., Fuerst S., et al. Prophylactic platelet transfusions are not necessary for clinically stable patients after autologous peripheral stem cell transplantation. Blood. 100:2002;57a. (abstr)
19. Miller A.B., Hoogstraten B., Stachet M., et al. Reporting results of cancer treatment. Cancer. 47:1981;207-214
20. Zumberg M.S., del Rosario M.L., Nejame C.F., et al. A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients 10,000/μL versus 20,000/μL trigger. Biol Blood Marrow Transplant. 8:2002;569-576
21. Rebulla P., Finazzi G., Marangoni F., et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med. 337:1997;1870-1875
22. 9/l A prospective comparative trial in 105 patients with acute myeloid leukemia-. Blood. 91:1998;3601-3606
23. Heckman K.D., Weiner G.J., Davis C.S., et al. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia 10,000/μL versus 20,000/μL. J Clin Oncol. 15:1997;1143-1149
24. Gil-Fernandez J.J., Alegre A., Fernandez-Villalta M.J., et al. Clinical results of a stringent policy on prophylactic platelet transfusion Non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution. Bone Marrow Transplant. 18:1996;931-935
25. Lawrence J.B., Yomtovian R., Hammons T., et al. Lowering the prophylactic platelet transfusion threshold A prospective analysis. Leuk Lymph. 41:2001;67-76
26. Navarro J.T., Hernandez J.A., Ribera J.M., et al. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia 10,000/μL versus 20,000/μL. Haematologica. 83:1998;998-1000
27. Gmür J., Burger J., Schanz U., et al. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukemia. Lancet. 338:1991;1223-1226
28. Fanning J., Hilgers R.D., Murray K.P., et al. Conservative management of chemotherapeutic-induced thrombocytopenia in women with gynecologic cancers. Gynecol Oncol. 59:1995;191-193
29. Sagmeister M., Oec L., Gmür J. A restrictive platelet transfusion policy allowing long-term support of outpatients with severe aplastic anemia. Blood. 93:1999;3124-3126
30. Slichter S.J., LeBlanc R., Jones M.K., et al. Quantitative analysis of bleeding risk in cancer patients prophylactically transfused at platelet counts of 5,000, 10,000, or 20,000 platelets/μl. Blood. 94:1999;376a. (suppl, abstr)
31. Kuter D.J., Rosenberg R.D. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during Busulfan-induced thrombocytopenia in the rabbit. Blood. 85:1995;2720-2730
32. Möller P., Andersson P.O., Andersson A.C., et al. Plasma thrombopoietin concentrations in response to platelet transfusion therapy. Acta Haematol. 102:2000;131-134
33. Kuter D.J., Beeler D.L., Rosenberg R.D. The purification of megapoietin A physiological regulator of megakaryocyte growth and production. Proc Nat Acad Sci U S A. 91:1994;11104-11108
34. Bartley T.D., Bogenberger J., Hunt P., et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell. 177:1994;1117-1124
35. Lok S., Kaushansky K., Holly R.D., et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 369:1994;568-571
36. Debili N., Wendling F., Cosman D., et al. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood. 85:1995;391-401
37. Wendling F., Maraskovsky E., Debili N., et al. C-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature. 369:1994;571-574
38. Friedmann A.M., Sengul H., Lehmann H., et al. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. Transfus Med Rev. 16:2002;34-45
39. Lawrence J.B., Yomtovian R.A., Dillman C., et al. Reliability of automated platelet counts Comparison with manual method and utility for prediction of clinical bleeding. Am J Hematol. 48:1995;244-250
40. Bernstein S.H., Nademanee A.P., Vose J.M., et al. A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. Blood. 91:1998;3509-3517
41. Tornebohm E., Lockner D., Paul C. A retrospective analysis of bleeding complications in 438 patients with acute leukemia during the years 1972-1991. Eur J Haematol. 50:1993;160-167
42. Nevo S., Swan V., Enger C., et al. Acute bleeding after bone marrow transplantation Incidence and effect on survival. A quantitative analysis in 1,402 patients. Blood. 91:1998;1469-1477
43. Belt R.J., Leite C., Haas C.D., et al. Incidence of hemorrhagic complications in patients with cancer. JAMA. 239:1978;2571-2574
44. Dutcher J.P., Schiffer C.A., Aisner J., et al. Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumors. Cancer. 53:1984;557-562
45. Goldberg G.L., Gibbon D.G., Smith H.O., et al. Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer. J Clin Oncol. 12:1994;2317-2320
46. Elting L.S., Rubenstein E.B., Martin C.G., et al. Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia. J Clin Oncol. 19:2001;1137-1146
47. Schiffer C.A., Anderson K.C., Bennett C.L., et al. Platelet transfusion for patients with cancer Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 19:2001;1519-1538